Europe Chinese Hamster Ovary (CHO) Cells Market - Industry Trends and Forecast to 2030

Description

List of Tables

The Europe Chinese Hamster Ovary (CHO) cells market is expected to reach USD 190,312.23 thousand by 2030 from USD 104,656.51 thousand in 2022, growing at a substantial CAGR of 8.2% in the forecast period of 2023 to 2030.

Market Segmentation

Europe Chinese Hamster Ovary (CHO) Cells Market, By Type (Services and Product), System (Metabolic Selection System, Antibiotic Selection System, and Others), Application (Biologics and Medical Research), End User (Biopharmaceutical Companies, Biotechnology Companies, Clinical Development and Manufacturing Organizations, Clinical Research Organizations, Academic Institutes and Research Organizations, and Others), Distribution Channel (Direct Tenders, Retail Sales, and Others), Country (Germany, U.K., France, Russia, Italy, Spain, Turkey, Poland, Belgium, Netherlands, Switzerland, Denmark, Sweden, Norway, Finland, and Rest of Europe) - Industry Trends and Forecast to 2030.

Overview of the Europe Chinese Hamster Ovary (CHO) Cells Market Dynamics

Driver
Rising use of CHO cells in the genetic study
Restraint
High cost of CHO cell-based production
Opportunity
Continuous development of cell culture technologies

Market Players

Some of the major market players operating in the Europe Chinese Hamster Ovary (CHO) cells market are:

Abeomics
AcceGen
Applied Biological Materials Inc. (abm)
ATCC
BPS Bioscience, Inc.
CLS Cell Lines Service GmbH
Curia Global, Inc.
Cytiva
GenTarget Inc.
GTP Bioways
Horizon Discovery Ltd.
Lonza
Merck KGaA
Promega Corporation
RayBiotech Life, Inc.
Sartorius AG
Thermo Fisher Scientific Inc.

1 INTRODUCTION 24

1.1 OBJECTIVES OF THE STUDY 24
1.2 MARKET DEFINITION 24
1.3 OVERVIEW OF THE EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET 24
1.4 LIMITATIONS 26
1.5 MARKETS COVERED 26

2 MARKET SEGMENTATION 28

2.1 MARKETS COVERED 28
2.2 GEOGRAPHICAL SCOPE 29
2.3 YEARS CONSIDERED FOR THE STUDY 29
2.4 CURRENCY AND PRICING 29
2.5 DBMR TRIPOD DATA VALIDATION MODEL 30
2.6 MULTIVARIATE MODELLING 33
2.7 BY TYPE LIFELINE CURVE 34
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 35
2.9 DBMR MARKET POSITION GRID 36
2.10 MARKET APPLICATION COVERAGE GRID 37
2.11 VENDOR SHARE ANALYSIS 38
2.12 SECONDARY SOURCES 39
2.13 ASSUMPTIONS 39

3 EXECUTIVE SUMMARY 40

4 PREMIUM INSIGHTS 42

4.1 PESTEL ANALYSIS MODEL 43
4.2 PORTER'S 5 FORCES 44

5 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, REGULATIONS 45

6 MARKET OVERVIEW 46

6.1 DRIVERS 48
- 6.1.1 RISING USE OF CHO CELLS IN THE GENETIC STUDY 48
- 6.1.2 GROWING DEMAND FOR BIOPHARMACEUTICALS 49
- 6.1.3 RISING INVESTMENTS IN BIOTECHNOLOGY R&D 49
- 6.1.4 RISING DEMAND FOR MONOCLONAL ANTIBODIES 51
6.2 RESTRAINTS 52
- 6.2.1 HIGH-COST OF CHO CELL-BASED PRODUCTION 52
- 6.2.2 STRICT REGULATORY REQUIREMENTS FOR CHO CELL-BASED PRODUCTION 53
6.3 OPPORTUNITIES 54
- 6.3.1 CONTINUOUS DEVELOPMENT OF CELL CULTURE TECHNOLOGIES 54
- 6.3.2 RISING NUMBER OF APPLICATIONS OF CHO CELLS 55
6.4 CHALLENGES 56
- 6.4.1 TIME-CONSUMING AND INCONSISTENCY IN THE CHO CELL LINE DEVELOPMENT PROCESS 56
- 6.4.2 CONTAMINATION RISK OF CHO CELL CULTURES 57

7 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE 59

7.1 OVERVIEW 60
7.2 SERVICES 62
7.3 PRODUCT 63
- 7.3.1 CHO-DXB11 63
- 7.3.2 CHO-K1 63
  - 7.3.2.1 CHO-K1 ATCC 64
  - 7.3.2.2 CHO-K1 ECACC 64
  - 7.3.2.3 Others 64
- 7.3.3 CHO-DG44 64
- 7.3.4 CHO-S 64
- 7.3.5 OTHERS 64

8 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM 65

8.1 OVERVIEW 66
8.2 METABOLIC SELECTION SYSTEM 68
8.3 ANTIBIOTIC SELECTION SYSTEM 68
8.4 OTHERS 69

9 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION 70

9.1 OVERVIEW 71
9.2 BIOLOGICS 74
- 9.2.1 MONOCLONAL ANTIBODIES 74
- 9.2.2 ENZYMES 74
- 9.2.3 CYTOKINES 74
- 9.2.4 CLOTTING FACTORS 74
- 9.2.5 HORMONES 75
- 9.2.6 FC-FUSION PROTIEN 75
- 9.2.7 OTHERS 75
9.3 MEDICAL RESEARCH 75

10 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER 76

10.1 OVERVIEW 77
10.2 BIOPHARMACEUTICAL COMPANIES 80
- 10.2.1 MEDIUM 80
- 10.2.2 SMALL 80
10.3 BIOTECHNOLOGY COMPANIES 80
- 10.3.1 MEDIUM 81
- 10.3.2 SMALL 81
10.4 CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS 82
- 10.4.1 MEDIUM 82
- 10.4.2 SMALL 82
10.5 CLINICAL RESEARCH ORGANIZATIONS 82
- 10.5.1 MEDIUM 83
- 10.5.2 SMALL 83
10.6 ACADEMIC INSTITUTES AND RESEARCH ORGANIZATIONS 83
10.7 OTHERS 83

11 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL 84

11.1 OVERVIEW 85
11.2 DIRECT TENDERS 87
11.3 RETAIL SALES 87
11.4 OTHERS 88

12 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY EUROPE 89

12.1 EUROPE 89
- 12.1.1 GERMANY 91
- 12.1.2 U.K. 96
- 12.1.3 FRANCE 100
- 12.1.4 RUSSIA 104
- 12.1.5 ITALY 108
- 12.1.6 SPAIN 112
- 12.1.7 TURKEY 116
- 12.1.8 POLAND 120
- 12.1.9 BELGIUM 124
- 12.1.10 NETHERLANDS 128
- 12.1.11 SWITZERLAND 132
- 12.1.12 DENMARK 136
- 12.1.13 SWEDEN 140
- 12.1.14 NORWAY 144
- 12.1.15 FINLAND 148
- 12.1.16 REST OF EUROPE 152

13 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, COMPANY LANDSCAPE 153

13.1 COMPANY SHARE ANALYSIS: EUROPE 153

14 SWOT ANALYSIS 154

15 COMPANY PROFILES 155

15.1 SARTORIUS AG 155
- 15.1.1 COMPANY SNAPSHOT 155
- 15.1.2 REVENUE ANALYSIS 155
- 15.1.3 PRODUCT PORTFOLIO 156
- 15.1.4 RECENT DEVELOPMENT 156
15.2 LONZA 157
- 15.2.1 COMPANY SNAPSHOT 157
- 15.2.2 REVENUE ANALYSIS 157
- 15.2.3 PRODUCT PORTFOLIO 158
- 15.2.4 RECENT DEVELOPMENT 158
15.3 MERCK KGAA 159
- 15.3.1 COMPANY SNAPSHOT 159
- 15.3.2 REVENUE ANALYSIS 159
- 15.3.3 PRODUCT PORTFOLIO 160
- 15.3.4 RECENT DEVELOPMENT 160
15.4 CYTIVA 161
- 15.4.1 COMPANY SNAPSHOT 161
- 15.4.2 PRODUCT PORTFOLIO 161
- 15.4.3 RECENT DEVELOPMENT 161
15.5 THERMO FISHER SCIENTIFIC INC. 162
- 15.5.1 COMPANY SNAPSHOT 162
- 15.5.2 REVENUE ANALYSIS 162
- 15.5.3 PRODUCT PORTFOLIO 163
- 15.5.4 RECENT DEVELOPMENT 163
15.6 ABEOMICS 164
- 15.6.1 COMPANY SNAPSHOT 164
- 15.6.2 PRODUCT PORTFOLIO 164
- 15.6.3 RECENT DEVELOPMENT 164
15.7 ACCEGEN 165
- 15.7.1 COMPANY SNAPSHOT 165
- 15.7.2 PRODUCT PORTFOLIO 165
- 15.7.3 RECENT DEVELOPMENT 165
15.8 APPLIED BIOLOGICAL MATERIALS INC. (ABM) 166
- 15.8.1 COMPANY SNAPSHOT 166
- 15.8.2 PRODUCT PORTFOLIO 166
- 15.8.3 RECENT DEVELOPMENT 166
15.9 ATCC 167
- 15.9.1 COMPANY SNAPSHOT 167
- 15.9.2 PRODUCT PORTFOLIO 167
- 15.9.3 RECENT DEVELOPMENT 168
15.10 BPS BIOSCIENCE, INC. 169
- 15.10.1 COMPANY SNAPSHOT 169
- 15.10.2 PRODUCT PORTFOLIO 169
- 15.10.3 RECENT DEVELOPMENT 169
15.11 CLS CELL LINES SERVICE GMBH 170
- 15.11.1 COMPANY SNAPSHOT 170
- 15.11.2 PRODUCT PORTFOLIO 170
- 15.11.3 RECENT DEVELOPMENT 170
15.12 CURIA GLOBAL, INC. 171
- 15.12.1 COMPANY SNAPSHOT 171
- 15.12.2 PRODUCT PORTFOLIO 171
- 15.12.3 RECENT DEVELOPMENT 172
15.13 GENTARGET INC. 173
- 15.13.1 COMPANY SNAPSHOT 173
- 15.13.2 PRODUCT PORTFOLIO 173
- 15.13.3 RECENT DEVELOPMENT 173
15.14 HORIZON DISCOVERY LTD. 174
- 15.14.1 COMPANY SNAPSHOT 174
- 15.14.2 PRODUCT PORTFOLIO 174
- 15.14.3 RECENT DEVELOPMENT 175
15.15 PROMEGA CORPORATION 176
- 15.15.1 COMPANY SNAPSHOT 176
- 15.15.2 PRODUCT PORTFOLIO 176
- 15.15.3 RECENT DEVELOPMENT 176
15.16 RAYBIOTECH LIFE, INC. 177
- 15.16.1 COMPANY SNAPSHOT 177
- 15.16.2 PRODUCT PORTFOLIO 177
- 15.16.3 RECENT DEVELOPMENT 177

16 QUESTIONNAIRE 178

17 RELATED REPORTS 182

LIST OF TABLES

TABLE 1 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2022-2030 (USD THOUSAND) 62
TABLE 2 EUROPE PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 63
TABLE 3 EUROPE CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 63
TABLE 4 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND) 68
TABLE 5 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 73
TABLE 6 EUROPE BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 74
TABLE 7 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 79
TABLE 8 EUROPE BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 80
TABLE 9 EUROPE BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 80
TABLE 10 EUROPE CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 82
TABLE 11 EUROPE CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 82
TABLE 12 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 (USD THOUSAND) 87
TABLE 13 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY COUNTRY, 2021-2030 (USD THOUSAND) 90
TABLE 14 GERMANY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 91
TABLE 15 GERMANY PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 91
TABLE 16 GERMANY PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 91
TABLE 17 GERMANY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 92
TABLE 18 GERMANY CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 92
TABLE 19 GERMANY CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 92
TABLE 20 GERMANY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 92
TABLE 21 GERMANY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND) 93
TABLE 22 GERMANY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 93
TABLE 23 GERMANY BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 93
TABLE 24 GERMANY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 94
TABLE 25 GERMANY BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 94
TABLE 26 GERMANY BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 94
TABLE 27 GERMANY CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 94
TABLE 28 GERMANY CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 95
TABLE 29 GERMANY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 95
TABLE 30 U.K. CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 96
TABLE 31 U.K. PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 96
TABLE 32 U.K. PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 96
TABLE 33 U.K. CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 96
TABLE 34 U.K. CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 97
TABLE 35 U.K. CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 97
TABLE 36 U.K. CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 97
TABLE 37 U.K. CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND) 97
TABLE 38 U.K. CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 97
TABLE 39 U.K. BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 98
TABLE 40 U.K. CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 98
TABLE 41 U.K. BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 98
TABLE 42 U.K. BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 99
TABLE 43 U.K. CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 99
TABLE 44 U.K. CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 99
TABLE 45 U.K. CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 99
TABLE 46 FRANCE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 100
TABLE 47 FRANCE PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 100
TABLE 48 FRANCE PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 100
TABLE 49 FRANCE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 100
TABLE 50 FRANCE CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 101
TABLE 51 FRANCE CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 101
TABLE 52 FRANCE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 101
TABLE 53 FRANCE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND) 101
TABLE 54 FRANCE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 101
TABLE 55 FRANCE BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 102
TABLE 56 FRANCE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 102
TABLE 57 FRANCE BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 102
TABLE 58 FRANCE BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 103
TABLE 59 FRANCE CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 103
TABLE 60 FRANCE CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 103
TABLE 61 FRANCE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 103
TABLE 62 RUSSIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 104
TABLE 63 RUSSIA PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 104
TABLE 64 RUSSIA PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 104
TABLE 65 RUSSIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 104
TABLE 66 RUSSIA CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 105
TABLE 67 RUSSIA CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 105
TABLE 68 RUSSIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 105
TABLE 69 RUSSIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND) 105
TABLE 70 RUSSIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 105
TABLE 71 RUSSIA BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 106
TABLE 72 RUSSIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 106
TABLE 73 RUSSIA BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 106
TABLE 74 RUSSIA BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 106
TABLE 75 RUSSIA CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 107
TABLE 76 RUSSIA CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 107
TABLE 77 RUSSIA CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 107
TABLE 78 ITALY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 108
TABLE 79 ITALY PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 108
TABLE 80 ITALY PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 108
TABLE 81 ITALY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 108
TABLE 82 ITALY CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 109
TABLE 83 ITALY CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 109
TABLE 84 ITALY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 109
TABLE 85 ITALY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND) 109
TABLE 86 ITALY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 109
TABLE 87 ITALY BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 110
TABLE 88 ITALY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 110
TABLE 89 ITALY BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 110
TABLE 90 ITALY BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 110
TABLE 91 ITALY CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 111
TABLE 92 ITALY CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 111
TABLE 93 ITALY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 111
TABLE 94 SPAIN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 112
TABLE 95 SPAIN PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 112
TABLE 96 SPAIN PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 112
TABLE 97 SPAIN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 112
TABLE 98 SPAIN CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 113
TABLE 99 SPAIN CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 113
TABLE 100 SPAIN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 113
TABLE 101 SPAIN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND) 113
TABLE 102 SPAIN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 113
TABLE 103 SPAIN BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 114
TABLE 104 SPAIN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 114
TABLE 105 SPAIN BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 114
TABLE 106 SPAIN BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 114
TABLE 107 SPAIN CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 115
TABLE 108 SPAIN CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 115
TABLE 109 SPAIN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 115
TABLE 110 TURKEY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 116
TABLE 111 TURKEY PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 116
TABLE 112 TURKEY PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 116
TABLE 113 TURKEY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 116
TABLE 114 TURKEY CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 117
TABLE 115 TURKEY CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 117
TABLE 116 TURKEY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 117
TABLE 117 TURKEY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND) 117
TABLE 118 TURKEY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 117
TABLE 119 TURKEY BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 118
TABLE 120 TURKEY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 118
TABLE 121 TURKEY BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 118
TABLE 122 TURKEY BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 118
TABLE 123 TURKEY CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 119
TABLE 124 TURKEY CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 119
TABLE 125 TURKEY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 119
TABLE 126 POLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 120
TABLE 127 POLAND PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 120
TABLE 128 POLAND PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 120
TABLE 129 POLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 120
TABLE 130 POLAND CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 121
TABLE 131 POLAND CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 121
TABLE 132 POLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 121
TABLE 133 POLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND) 121
TABLE 134 POLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 121
TABLE 135 POLAND BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 122
TABLE 136 POLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 122
TABLE 137 POLAND BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 122
TABLE 138 POLAND BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 122
TABLE 139 POLAND CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 123
TABLE 140 POLAND CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 123
TABLE 141 POLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 123
TABLE 142 BELGIUM CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 124
TABLE 143 BELGIUM PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 124
TABLE 144 BELGIUM PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 124
TABLE 145 BELGIUM CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 124
TABLE 146 BELGIUM CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 125
TABLE 147 BELGIUM CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 125
TABLE 148 BELGIUM CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 125
TABLE 149 BELGIUM CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND) 125
TABLE 150 BELGIUM CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 125
TABLE 151 BELGIUM BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 126
TABLE 152 BELGIUM CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 126
TABLE 153 BELGIUM BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 126
TABLE 154 BELGIUM BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 126
TABLE 155 BELGIUM CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 127
TABLE 156 BELGIUM CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 127
TABLE 157 BELGIUM CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 127
TABLE 158 NETHERLANDS CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 128
TABLE 159 NETHERLANDS PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 128
TABLE 160 NETHERLANDS PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 128
TABLE 161 NETHERLANDS CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 128
TABLE 162 NETHERLANDS CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 129
TABLE 163 NETHERLANDS CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 129
TABLE 164 NETHERLANDS CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 129
TABLE 165 NETHERLANDS CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND) 129
TABLE 166 NETHERLANDS CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 129
TABLE 167 NETHERLANDS BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 130
TABLE 168 NETHERLANDS CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 130
TABLE 169 NETHERLANDS BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 130
TABLE 170 NETHERLANDS BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 130
TABLE 171 NETHERLANDS CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 131
TABLE 172 NETHERLANDS CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 131
TABLE 173 NETHERLANDS CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 131
TABLE 174 SWITZERLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 132
TABLE 175 SWITZERLAND PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 132
TABLE 176 SWITZERLAND PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 132
TABLE 177 SWITZERLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 132
TABLE 178 SWITZERLAND CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 133
TABLE 179 SWITZERLAND CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 133
TABLE 180 SWITZERLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 133
TABLE 181 SWITZERLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND) 133
TABLE 182 SWITZERLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 133
TABLE 183 SWITZERLAND BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 134
TABLE 184 SWITZERLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 134
TABLE 185 SWITZERLAND BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 134
TABLE 186 SWITZERLAND BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 134
TABLE 187 SWITZERLAND CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 135
TABLE 188 SWITZERLAND CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 135
TABLE 189 SWITZERLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 135
TABLE 190 DENMARK CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 136
TABLE 191 DENMARK PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 136
TABLE 192 DENMARK PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 136
TABLE 193 DENMARK CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 136
TABLE 194 DENMARK CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 137
TABLE 195 DENMARK CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 137
TABLE 196 DENMARK CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 137
TABLE 197 DENMARK CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND) 137
TABLE 198 DENMARK CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 137
TABLE 199 DENMARK BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 138
TABLE 200 DENMARK CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 138
TABLE 201 DENMARK BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 138
TABLE 202 DENMARK BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 138
TABLE 203 DENMARK CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 139
TABLE 204 DENMARK CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 139
TABLE 205 DENMARK CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 139
TABLE 206 SWEDEN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 140
TABLE 207 SWEDEN PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 140
TABLE 208 SWEDEN PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 140
TABLE 209 SWEDEN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 140
TABLE 210 SWEDEN CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 141
TABLE 211 SWEDEN CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 141
TABLE 212 SWEDEN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 141
TABLE 213 SWEDEN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND) 141
TABLE 214 SWEDEN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 141
TABLE 215 SWEDEN BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 142
TABLE 216 SWEDEN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 142
TABLE 217 SWEDEN BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 142
TABLE 218 SWEDEN BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 142
TABLE 219 SWEDEN CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 143
TABLE 220 SWEDEN CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 143
TABLE 221 SWEDEN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 143
TABLE 222 NORWAY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 144
TABLE 223 NORWAY PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 144
TABLE 224 NORWAY PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 144
TABLE 225 NORWAY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 144
TABLE 226 NORWAY CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 145
TABLE 227 NORWAY CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 145
TABLE 228 NORWAY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 145
TABLE 229 NORWAY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND) 145
TABLE 230 NORWAY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 145
TABLE 231 NORWAY BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 146
TABLE 232 NORWAY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 146
TABLE 233 NORWAY BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 146
TABLE 234 NORWAY BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 146
TABLE 235 NORWAY CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 147
TABLE 236 NORWAY CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 147
TABLE 237 NORWAY CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 147
TABLE 238 FINLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 148
TABLE 239 FINLAND PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 148
TABLE 240 FINLAND PRODUCT IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 148
TABLE 241 FINLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 148
TABLE 242 FINLAND CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 149
TABLE 243 FINLAND CHO-K1 IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 ASP 149
TABLE 244 FINLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY PRODUCT TYPE, 2021-2030 (UNITS) 149
TABLE 245 FINLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY SYSTEM, 2021-2030 (USD THOUSAND) 149
TABLE 246 FINLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 149
TABLE 247 FINLAND BIOLOGICS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY APPLICATION, 2021-2030 (USD THOUSAND) 150
TABLE 248 FINLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY END USER, 2021-2030 (USD THOUSAND) 150
TABLE 249 FINLAND BIOPHARMACEUTICAL COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 150
TABLE 250 FINLAND BIOTECHNOLOGY COMPANIES IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 151
TABLE 251 FINLAND CLINICAL DEVELOPMENT AND MANUFACTURING ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 151
TABLE 252 FINLAND CLINICAL RESEARCH ORGANIZATIONS IN CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 151
TABLE 253 FINLAND CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD THOUSAND) 151
TABLE 254 REST OF EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET, BY TYPE, 2021-2030 (USD THOUSAND) 152

LIST OF FIGURES

FIGURE 1 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: SEGMENTATION 28
FIGURE 2 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: DATA TRIANGULATION 30
FIGURE 3 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: DROC ANALYSIS 31
FIGURE 4 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS 32
FIGURE 5 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: COMPANY RESEARCH ANALYSIS 32
FIGURE 6 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: INTERVIEW DEMOGRAPHICS 35
FIGURE 7 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: DBMR MARKET POSITION GRID 36
FIGURE 8 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: MARKET APPLICATION COVERAGE GRID 37
FIGURE 9 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: VENDOR SHARE ANALYSIS 38
FIGURE 10 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: SEGMENTATION 41
FIGURE 11 GROWING DEMAND FOR BIOPHARMACEUTICALS IS EXPECTED TO DRIVE THE GROWTH OF THE EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET GROWTH IN THE FORECAST PERIOD OF 2023 TO 2030 42
FIGURE 12 TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET IN THE FORECAST PERIOD OF 2023 AND 2030 42
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE CHINESE HAMSTER OVARY CELLS (CHO) MARKET 47
FIGURE 14 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY TYPE, 2022 60
FIGURE 15 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY TYPE, 2023-2030 (USD THOUSAND) 61
FIGURE 16 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY TYPE, CAGR (2023-2030) 61
FIGURE 17 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY TYPE, LIFELINE CURVE 62
FIGURE 18 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY SYSTEM, 2022 66
FIGURE 19 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY SYSTEM, 2023-2030 (USD THOUSAND) 67
FIGURE 20 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY SYSTEM, CAGR (2023-2030) 67
FIGURE 21 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY SYSTEM, LIFELINE CURVE 68
FIGURE 22 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY APPLICATION, 2022 71
FIGURE 23 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY APPLICATION, 2023-2030 (USD THOUSAND) 72
FIGURE 24 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY APPLICATION, CAGR (2023-2030) 72
FIGURE 25 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY APPLICATION, LIFELINE CURVE 73
FIGURE 26 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY END USER, 2022 77
FIGURE 27 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY END USER, 2023-2030 (USD THOUSAND) 78
FIGURE 28 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY END USER, CAGR (2023-2030) 78
FIGURE 29 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY END USER, LIFELINE CURVE 79
FIGURE 30 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY DISTRIBUTION CHANNEL, 2022 85
FIGURE 31 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD THOUSAND) 86
FIGURE 32 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 86
FIGURE 33 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 87
FIGURE 34 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: SNAPSHOT (2022) 89
FIGURE 35 EUROPE CHINESE HAMSTER OVARY (CHO) CELLS MARKET: COMPANY SHARE 2022 (%) 153